<?xml version="1.0"?>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:title>The FAT score, a fibrosis score of adipose tissue : predicting weight-loss outcome after gastric bypass</dc:title>
  <dc:creator>Bel Lassen, P.</dc:creator>
  <dc:creator>Charlotte, F.</dc:creator>
  <dc:creator>Liu, Y.</dc:creator>
  <dc:creator>Bedossa, P.</dc:creator>
  <dc:creator>Le Naour, G.</dc:creator>
  <dc:creator>Tordjman, J.</dc:creator>
  <dc:creator>Poitou, C.</dc:creator>
  <dc:creator>Bouillot, J. L.</dc:creator>
  <dc:creator>Genser, L.</dc:creator>
  <dc:creator>/Zucker, Jean-Daniel</dc:creator>
  <dc:creator>Sokolovska, N.</dc:creator>
  <dc:creator>Aron-Wisnewsky, J.</dc:creator>
  <dc:creator>Clement, K.</dc:creator>
  <dc:description>Context: Bariatric surgery (BS) induces major and sustainable weight loss in many patients. Factors predicting poor weight-loss response (PR) need to be identified to improve patient care. Quantification of subcutaneous adipose tissue (scAT) fibrosis is negatively associated with post-BS weight loss, but whether it could constitute a predictor applicable in clinical routine remains to be demonstrated. Objective: To create a semiquantitative score evaluating scAT fibrosis and test its predictive value on weight-loss response after Roux-en-Y gastric bypass (RYGB). Methods: We created a fibrosis score of adipose tissue (FAT score) integrating perilobular and pericellular fibrosis. Using this score, we characterized 183 perioperative scAT biopsy specimens from severely obese patients who underwent RYGB (n = 85 from a training cohort; n = 98 from a confirmation cohort). PR to RYGB was defined as &lt;28% of total weight loss at 1 year (lowest tertile). The link between FAT score and PR was tested in univariate and multivariate models. Results: FAT score was directly associated with increasing scAT fibrosis measured by a standard quantification method (P for trend &lt;0.001). FAT score interobserver agreement was good (kappa = 0.76). FAT score &gt;= 2 was significantly associated with PR. The association remained significant after adjustment for age, diabetes status, hypertension, percent fat mass, and interleukin-6 level (adjusted odds ratio, 3.6; 95% confidence interval, 1.8 to 7.2; P = 0.003). Conclusions: The FAT score is a new, simple, semiquantitative evaluation of human scAT fibrosis that may help identify patients with a potential limited weight-loss response to RYGB.</dc:description>
  <dc:date>2017</dc:date>
  <dc:type>text</dc:type>
  <dc:identifier>https://www.documentation.ird.fr/hor/fdi:010084988</dc:identifier>
  <dc:identifier>fdi:010084988</dc:identifier>
  <dc:identifier>Bel Lassen P., Charlotte F., Liu Y., Bedossa P., Le Naour G., Tordjman J., Poitou C., Bouillot J. L., Genser L., Zucker Jean-Daniel, Sokolovska N., Aron-Wisnewsky J., Clement K.. The FAT score, a fibrosis score of adipose tissue : predicting weight-loss outcome after gastric bypass. 2017, 102 (7),  2443-2453</dc:identifier>
  <dc:language>EN</dc:language>
</oai_dc:dc>
